Literature DB >> 28806103

Hsp83 loss suppresses proteasomal activity resulting in an upregulation of caspase-dependent compensatory autophagy.

Courtney Choutka1,2, Lindsay DeVorkin1,2, Nancy Erro Go1,2, Ying-Chen Claire Hou1, Annie Moradian1,3, Gregg B Morin1,4, Sharon M Gorski1,2,5.   

Abstract

The 2 main degradative pathways that contribute to proteostasis are the ubiquitin-proteasome system and autophagy but how they are molecularly coordinated is not well understood. Here, we demonstrate an essential role for an effector caspase in the activation of compensatory autophagy when proteasomal activity is compromised. Functional loss of Hsp83, the Drosophila ortholog of human HSP90 (heat shock protein 90), resulted in reduced proteasomal activity and elevated levels of the effector caspase Dcp-1. Surprisingly, genetic analyses showed that the caspase was not required for cell death in this context, but instead was essential for the ensuing compensatory autophagy, female fertility, and organism viability. The zymogen pro-Dcp-1 was found to interact with Hsp83 and undergo proteasomal regulation in an Hsp83-dependent manner. Our work not only reveals unappreciated roles for Hsp83 in proteasomal activity and regulation of Dcp-1, but identifies an effector caspase as a key regulatory factor for sustaining adaptation to cell stress in vivo.

Entities:  

Keywords:  Dcp-1; Drosophila; Hsp83; apoptosis; caspase; compensatory autophagy; heat-shock protein; ubiquitin-proteasome system

Mesh:

Substances:

Year:  2017        PMID: 28806103      PMCID: PMC5612217          DOI: 10.1080/15548627.2017.1339004

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


Introduction

Proteostasis, or protein homeostasis, is a term that describes how the proteome is regulated and maintained to protect cellular integrity. Loss of proteostasis is a common feature of aging and diseases such as cancer and neurogenerative disorders as it causes inappropriate protein aggregate formation in various tissues. This aggregation is routinely managed by the proteostasis network, a network defined by macromolecular machines that contribute to maintenance of proteome integrity by coordinating protein synthesis, folding, disaggregation, and degradation. The 2 main degradative pathways that contribute to proteostasis are the ubiquitin-proteasome system (UPS) and autophagy. The proteasome consists of a core 20S cylindrical complex containing proteolytic sites with 2 19S regulatory complexes at each terminus to form the functional 26S proteasome. It serves as a major contributor to proteostasis by degrading misfolded, damaged proteins and regulatory proteins that have been targeted with ubiquitin, along with a few exceptional ubiquitin-free proteins that can also be degraded by the proteasome., Macroautophagy (hereafter referred to as autophagy) is a ubiquitous cellular process responsible for the degradation of long-lived proteins and turnover of organelles. It is a multistep process involving the formation of a double-membrane phagophore that engulfs cytoplasmic cargo and delivers it to the lysosome for degradation. In instances when the UPS is dysfunctional, it has been shown in multiple systems that compensatory autophagy contributes to protein degradation in an effort to maintain healthy cellular proteostasis. However, the molecular mechanisms that regulate compensatory autophagy are not well understood. Heat-shock proteins play a central role in proteostasis by controlling protein expression, acting as chaperones, and assisting with protein disaggregation and degradation. One of the most conserved, ubiquitous and highly-expressed heat-shock proteins is HSP90. HSP90 is a chaperone that alters protein configurations using ATP hydrolysis in a homodimer conformation, and has a large and growing “clientele” of greater than 200 proteins including numerous nuclear receptors, protein kinases, and transcription factors. The wide associations of HSP90 play a pivotal role in cell signaling and regulation of diverse cellular processes in normal biology and its dysregulation can have a marked effect on disease. HSP90 has emerged as a molecule of interest for cancer therapeutics as its upregulation, mislocalization and stabilization of proteins involved in metastasis, evasion of apoptosis and proliferation make it a prime target. While HSP90 is known to be an important hub for signaling and proteostasis, there are many HSP90 relationships and related pathways yet to be discovered. Investigations into the regulation of autophagy have led to the discovery of a Drosophila effector caspase, Dcp-1, that promotes starvation-induced autophagy in Drosophila oogenesis., Although caspases are well known for their role in apoptosis, it is becoming increasingly evident that caspases have nonapoptotic functions in diverse processes such as immunity, differentiation, compensatory proliferation and autophagy. In an effort to elucidate the molecular mechanisms underlying Dcp-1-mediated autophagy regulation, an immune-affinity purification (IAP) and tandem mass spectrometry (MS/MS) assay has identified sesB, an adenine nucleotide translocase, as a downstream regulator of autophagy. Upstream factors and other downstream pathway components and their relationship to Dcp-1-mediated autophagy still remain largely unknown. In this paper we report 24 candidate Dcp-1-interacting proteins identified in the IAP-MS/MS screen, 13 of which were found to negatively regulate autophagic flux in vitro. We focused further on one of the identified interactors, Hsp83, since its human ortholog HSP90 has links to disease, proteostasis and a current ambiguous role in autophagy. In vivo analyses revealed that loss-of-function Hsp83 mutants induced autophagy and cell death during Drosophila mid-oogenesis. Biochemical analyses showed that Hsp83 binds to the zymogen pro-Dcp-1 and that the loss of Hsp83 led to elevated levels of cleaved and pro-Dcp-1 that were not due to transcriptional regulation. As an explanation for elevated levels of Dcp-1, we investigated the functionality of the UPS, and found that Hsp83 mutants had decreased proteasomal activity. The levels of Dcp-1 were increased in flies with suppressed proteasomal activity supporting that Dcp-1 itself is affected by the proteasome. Analysis of Dcp-1;Hsp83 double mutants indicated that Dcp-1 was responsible for autophagy induced in mid-stage egg chambers (MSECs) and larval fat bodies, female fertility and organism viability when Hsp83 function is compromised. Additionally, double RNAi experiments revealed that Dcp-1 is needed to induce autophagy when Hsp83 or the proteasomal subunit Rpn11 is knocked down. These findings indicate that Hsp83 is important for basal proteasomal activity and that loss of it causes an induction of Dcp-1-mediated compensatory autophagy.

Results

Proteomic analysis and RNAi screen identify candidate Dcp-1-interacting proteins that modulate autophagy

To identify candidate substrates and interactors of Dcp-1 that regulate starvation-induced autophagy, we took an IAP-MS/MS-based approach. Catalytically inactive Dcp-1 (Dcp-1CDrosophila l(2)mbn cells to stabilize the interactions that would normally be transient if there was proteolytic activity. Following immuno-affinity purification, cell lysates were analyzed by LC-MS/MS to identify copurifying proteins. A subset of 24 high-confidence candidate interacting proteins was identified that met the selection threshold detailed in Materials and methods (Table 1, S1). Using this method, we have previously reported sesB as an interacting partner of Dcp-1. We selected all 24 candidates for subsequent autophagy analyses, initially using a RNAi and LysoTracker® Green (LTG) flow cytometry strategy that we described previously. Of the 24 candidates, 13 showed a statistically significant increase in LTG fluorescence following RNAi and starvation treatment, indicating that these candidates act as potential negative regulators of autophagy (Fig. 1A). The 24 candidates were compared with control RNAi-treated cells: Rheb, a negative regulator of autophagy that significantly increased LTG fluorescence following starvation, and S6k, a positive regulator of autophagy that significantly reduced LTG fluorescence (Fig. 1A). A second set of nonoverlapping dsRNAs were designed and used to validate the LTG findings (Fig. S1). The 13 validated hits included the heat shock proteins Hsc70–4, Hsp70Aa, Hsp60A and Hsp83, translation initiation factor eIF4A, the chromatin remodeler Mi-2, the ribosomal constituent sta, the AAA+ ATPase TER94, the chloride intracellular channel protein Clic, the proteasome activator REG, and the mitochondrial proteins ATPsynβ, blw and sesB.
Table 1.

Candidate Dcp-1 interactors and substrates identified by mass spectrometry. Symbols, CG numbers and molecular functions are from FlyBase.

FlybaseSymbolCG NumberGene Ontology molecular functionMean log(e)Mean unique pepsUniProt human gene name# of Expts observed
14–3–3ζCG17870Protein binding, protein heterodimerization activity, protein homodimerization activity−9.61.75YWHAZ4
eEF1α1CG8280Translation elongation factor activity−273.75EEF1A14
Hsc70–4CG4264Chaperone binding−708.50HSPA84
Hsp83CG1242ATPase activity, coupled−324.75HSP90AA14
Jafrac1CG1633Thioredoxin peroxidase activity−304.00PRDX14
14–3–3εCG31196Protein binding; protein heterodimerization activity−233.33YWHAE3
blwCG3612Hydrogen exporting ATPase activity; phosphorylative mechanism−162.67ATP5A13
CCT2CG7033Unfolded protein binding; ATP binding−6.51.67CCT23
ClicCG10997Calcium ion binding; chloride channel activity; lipid binding−7.21.67CLIC23
eEF1βCG6341Translation elongation factor activity−102.00EEF1B23
Rack1CG7111Protein kinase c binding−3.81.33RACK13
sesBaCG16944ATP:ADP antiporter activity−274.00ANT23
sglCG10072UDP-glucose 6-dehydrogenase activity−8.11.67UGDH3
TER94CG2331ATPase activity; golgi & ER organization−162.67VCP3
Uba1CG1782Ubiquitin activating enzyme activity−435.67UBA13
ATPsynβCG11154Hydrogen exporting ATPase activity; phosphorylative mechanism−3.11.00ATP5B2
eEF1γCG11901Translation elongation factor activity−5.61.50EEF1G2
eIF4aCG9075Translation initiation factor activity; RNA helicase activity−173.00EIF4A12
Hsc70CbCG6603Chaperone binding−193.00HSPA42
Hsp60ACG12101Unfolded protein binding−4.71.50HSPD12
Hsp70AaCG31366ATP binding, response to hypoxia−191.00HSPA1A/1B/1L2
Mi-2CG8103Protein binding; nucleosome-dependent ATPase activity; chromatin binding−6.11.50CHD32
REGCG1591Endopeptidase inhibitor activity; endopeptidase activator activity−3.41.00PSME32
staCG14792Structural constituent of ribosome−5.81.50RPSA2

Notes. The mean number of unique peptides that corresponded to each gene and the mean X!Tandem log (e) score for the peptides identified are listed. The human gene names were determined from a BLAST analysis of the Drosophila genes against the human UniProt database. The list is ordered by number of observations made from 4 independent immuno-affinity purifications of the Dcp-1 protein (Expts) with the most being 4 out of 4 experiments and the least being 2. See Table S1 for all raw values.

reported in.

Figure 1.

Thirteen candidate Dcp-1 interactors modify LysoTracker® Green and autolysosomes in vitro (A) RNAi-treated l(2)mbn cells stained with LysoTracker® Green (LTG) and starved to measure autophagy-associated activity via flow cytometry. Error bars represent ± SEM(n = 3). Statistical significance was determined using one-way ANOVA with a Dunnet post-test. Knockdown of targets that significantly increased LTG levels are indicated in red (P < 0.05), and knockdown of targets that significantly decreased LTG levels are indicated in blue (P < 0.05). All samples were compared with the negative Amp control dsRNA (ampicillin resistance gene) that is shown in black. (B to G) Analysis of RFP-GFP-Atg8a puncta in RNAi-treated Drosophila S2 cells. At least 50 cells were counted per treatment (n = 3), and graphs represent the average number of autolysosomes per cell relative to the Amp control. Error bars represent the average ± SEM, and statistical significance was determined using one-way ANOVA with a Dunnet post-test. (B) Cells were subjected to nutrient rich or deprived conditions for 7 h in the presence or absence of 0.1 μM bafilomycin A1 (BafA1). ****P < 0.0001. (C) Cells were treated with Amp, Rheb, or S6k dsRNA and subjected to 7 h of starvation, *P < 0.05, ***P < 0.001. (D) Representative images of S2-RFP-GFP-Atg8a cells subjected to fed, starved, or starved + BafA1 conditions. (E) Representative images of S2-RFP-GFP-Atg8a cells treated with the indicated dsRNAs. (F) Cells were treated with the indicated dsRNAs and subjected to starvation conditions for 7 h. *P < 0.05, **P < 0.01, ***P < 0.001 ****P < 0.0001. (G) Representative images of S2-RFP-GFP-Atg8a cells treated with the indicated dsRNAs. Scale bars: 10 μm.

Candidate Dcp-1 interactors and substrates identified by mass spectrometry. Symbols, CG numbers and molecular functions are from FlyBase. Notes. The mean number of unique peptides that corresponded to each gene and the mean X!Tandem log (e) score for the peptides identified are listed. The human gene names were determined from a BLAST analysis of the Drosophila genes against the human UniProt database. The list is ordered by number of observations made from 4 independent immuno-affinity purifications of the Dcp-1 protein (Expts) with the most being 4 out of 4 experiments and the least being 2. See Table S1 for all raw values. reported in. Thirteen candidate Dcp-1 interactors modify LysoTracker® Green and autolysosomes in vitro (A) RNAi-treated l(2)mbn cells stained with LysoTracker® Green (LTG) and starved to measure autophagy-associated activity via flow cytometry. Error bars represent ± SEM(n = 3). Statistical significance was determined using one-way ANOVA with a Dunnet post-test. Knockdown of targets that significantly increased LTG levels are indicated in red (P < 0.05), and knockdown of targets that significantly decreased LTG levels are indicated in blue (P < 0.05). All samples were compared with the negative Amp control dsRNA (ampicillin resistance gene) that is shown in black. (B to G) Analysis of RFP-GFP-Atg8a puncta in RNAi-treated Drosophila S2 cells. At least 50 cells were counted per treatment (n = 3), and graphs represent the average number of autolysosomes per cell relative to the Amp control. Error bars represent the average ± SEM, and statistical significance was determined using one-way ANOVA with a Dunnet post-test. (B) Cells were subjected to nutrient rich or deprived conditions for 7 h in the presence or absence of 0.1 μM bafilomycin A1 (BafA1). ****P < 0.0001. (C) Cells were treated with Amp, Rheb, or S6k dsRNA and subjected to 7 h of starvation, *P < 0.05, ***P < 0.001. (D) Representative images of S2-RFP-GFP-Atg8a cells subjected to fed, starved, or starved + BafA1 conditions. (E) Representative images of S2-RFP-GFP-Atg8a cells treated with the indicated dsRNAs. (F) Cells were treated with the indicated dsRNAs and subjected to starvation conditions for 7 h. *P < 0.05, **P < 0.01, ***P < 0.001 ****P < 0.0001. (G) Representative images of S2-RFP-GFP-Atg8a cells treated with the indicated dsRNAs. Scale bars: 10 μm.

Candidate Dcp-1 interacting partners regulate autophagic flux in vitro

To investigate the role of candidate Dcp-1 substrates and interacting partners in autophagic flux in vitro, we monitored autolysosome formation using a Drosophila S2 cell line stably expressing RFP-GFP-Atg8a. Following autophagy induction, Atg8 becomes lipidated and inserted into the autophagosomal membrane. Here, the overlap of RFP and GFP fluorescence results in the formation of yellow puncta that signify autophagosomes. In the acidic environment of the autolysosome, GFP fluorescence is quenched, whereas RFP fluorescence remains, and the resulting red puncta indicate that flux through the lysosomal compartment has occurred., As expected, we observed a significant increase in the number of autolysosomes per cell following starvation and this was blocked following the addition of the late-stage autophagy inhibitor bafilomycin A1 (BafA1) (Fig. 1B, D). As an additional control, we monitored the formation of autolysosomes following RNAi-mediated knockdown of Rheb and S6k and found a significant increase and decrease, respectively, in the number of autolysosomes per cell (Fig. 1C, E). Candidate Dcp-1-interacting partners that modified LTG following starvation were next tested for their ability to mediate autophagic flux in vitro. We found that RNAi-mediated knockdown of all 13 candidates significantly increased the number of autolysosomes per cell following starvation compared with the control (Fig. 1F and G), indicating that these proteins negatively regulate starvation-induced autophagic flux in vitro. Knockdown of all 13 candidates in fed conditions also led to a statistically significant, although modest, increase in autolysosomes, with the greatest effects observed for the 4 heat-shock proteins identified (Fig. S1).

Loss of Hsp83 increases TUNEL staining, the percentage of mid-stage degenerating egg chambers (MSDECs) and autophagic flux

Our in vitro autophagy assays revealed that Dcp-1 may regulate, or may be regulated by, one or more of the 13 identified negative regulators of starvation-induced autophagy. Of the interacting partners identified, we chose to focus on Hsp83. To further confirm our in vitro findings that Hsp83 acts as a negative regulator of autophagy we designed additional Hsp83 dsRNAs and analyzed LTG levels by flow cytometry (Fig. S2). Two RNAi constructs used for further experiments were tested for efficacy and consistently achieved 65% to 80% knockdown (Fig. S2). For in vivo autophagy analyses, we chose to analyze Drosophila ovaries as nutrient deprivation leads to both Dcp-1 dependent cell death and autophagy., Loss-of-function studies were performed using transheterozygous (transhet) combinations of Hsp83 alleles because Hsp83 homozygous mutant flies are lethal., We examined the role of 2 transhet combinations with decreased Hsp83 function of Hsp83 alleles, Hsp83 with Hsp83 (Hsp83) and Hsp83 with Hsp83 (Hsp83), for their role in autophagy during Drosophila oogenesis by analyzing mid-stage egg chambers (MSECS). These alleles carry missense point mutations and the combinations were functionally screened by genetic complementation tests. Ovaries from Hsp83 and Hsp83 flies contained an increase in the percentage of degenerating MSECs (MSDECS) that stained positively for LysoTracker® Red (LTR) and TUNEL relative to control flies and balanced monoallelic Hsp83 mutants (Fig. 2A to C). MSECs undergoing cell death are characterized by nurse cell nuclear condensation and fragmentation, uptake of the germline by follicle cells and follicle cell death. These findings suggest that there is an increase in lysosomal activity, a key feature of autophagy, in addition to cell death.
Figure 2.

Loss of Hsp83 function leads to an increase in autophagy and cell death features in vivo. (A) Mid-stage egg chambers (MSECS) scored as being TUNEL positive, LysoTracker® Red (LTR)-positive or as having condensed degenerating nurse cell nuclei by DAPI (MSDEC) with percentages reported according to their genotype. At least 50 MSECs were counted per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Bonferroni post-test and compared with w, ***P < 0.001, ****P < 0.0001. (B, C) Representative MSDECs and nondegenerating MSECs stained with LTR, TUNEL and DAPI, scale bars: 25 μm. (B) MSDEC from an Hsp83 ovariole that scored positive for LTR and TUNEL staining. (C) Nondegenerating MSEC from Hsp83 scored as negative for LTR and TUNEL (D to I) MSECs were scored from flies expressing GFP-mCherry-Atg8a in the germline (UAsp-GFP-mCherry-DrAtg8a with single copies of the drivers otu-GAL4 and NGT-GAL4). Hsp83 and Hsp83 and Hsp83 from the same cross were analyzed together. (D) Percentage of MSDECs for the indicated genotypes is represented on the graph and reflects the mean of at least 100 MSECs scored per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, *P < 0.05. (E) Flies expressing GFP-mCherry-Atg8a in the germline were scored as either having more than 5 autolysosomes or less than or equal to 5 autolysosomes. The percentages shown reflect the mean of at least 100 MSECs scored per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, **P < 0.01. (F) to I) Representative images of MSECs expressing the construct GFP-mCherry-Atg8a, scale bar = 25μm. MSDECS found in (F) Hsp83 and (G) Hsp83. (H, I) Examples of nondegenerating MSECs from (H) Hsp83 and (I) Hsp83.

Loss of Hsp83 function leads to an increase in autophagy and cell death features in vivo. (A) Mid-stage egg chambers (MSECS) scored as being TUNEL positive, LysoTracker® Red (LTR)-positive or as having condensed degenerating nurse cell nuclei by DAPI (MSDEC) with percentages reported according to their genotype. At least 50 MSECs were counted per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Bonferroni post-test and compared with w, ***P < 0.001, ****P < 0.0001. (B, C) Representative MSDECs and nondegenerating MSECs stained with LTR, TUNEL and DAPI, scale bars: 25 μm. (B) MSDEC from an Hsp83 ovariole that scored positive for LTR and TUNEL staining. (C) Nondegenerating MSEC from Hsp83 scored as negative for LTR and TUNEL (D to I) MSECs were scored from flies expressing GFP-mCherry-Atg8a in the germline (UAsp-GFP-mCherry-DrAtg8a with single copies of the drivers otu-GAL4 and NGT-GAL4). Hsp83 and Hsp83 and Hsp83 from the same cross were analyzed together. (D) Percentage of MSDECs for the indicated genotypes is represented on the graph and reflects the mean of at least 100 MSECs scored per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, *P < 0.05. (E) Flies expressing GFP-mCherry-Atg8a in the germline were scored as either having more than 5 autolysosomes or less than or equal to 5 autolysosomes. The percentages shown reflect the mean of at least 100 MSECs scored per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, **P < 0.01. (F) to I) Representative images of MSECs expressing the construct GFP-mCherry-Atg8a, scale bar = 25μm. MSDECS found in (F) Hsp83 and (G) Hsp83. (H, I) Examples of nondegenerating MSECs from (H) Hsp83 and (I) Hsp83. As an additional measure to examine autophagic flux, we used the tandem-tagged Atg8a reporter system expressing GFP-mCherry-Atg8a in the germline of Hsp83 transhets in nutrient-rich conditions. Due to the nature of the cross, Hsp83 and either Hsp83 or Hsp83 were pooled and analyzed together. First, we confirmed that expression of the Atg8a reporter construct did not affect the frequency of MSDECs (Fig. 2D). Hsp83 and Hsp83 had very distinct MSDECs that had high levels of autolysosomes in comparison to the control Hsp83 heterozygotes (Fig. 2E-G). It was found that 75% to 90% of MSDECs had greater than 5 autolysosomes compared with only 15% to 20% when carrying one mutated Hsp83 allele (Fig. 2E). The nondegenerating MSECs in the mutant transhets and the controls looked morphologically normal and did not appear to have high levels of autophagic flux (Fig. 2H, I). From these studies we can conclude that loss of Hsp83 enhances the percentage of MSDECs undergoing autophagic flux. To determine if the phenotype is affected by the stress of nutrient deprivation, the flies were fed a sucrose-only diet for 4 to 5 d. Both the control Hsp83 heterozygotes and the mutant Hsp83 transhets showed an increase in autolysosomal activity in the early stage egg chambers. However, in the mutant Hsp83 transhets only, we observed an exacerbated phenotype of nearly obliterated mCherry-positive mid-stage egg chambers in contrast to the degenerating mid-stage egg chambers observed in fed conditions (Fig. S3).

Hsp83 interacts with pro-Dcp-1 and regulates its levels

To further understand the nature of the interaction between Hsp83 and Dcp-1, we tested if Hsp83 is cleaved by Dcp-1. In vitro cleavage assays were performed using catalytically active Dcp-1 (Dcp-1FL) and catalytically inactive Dcp-1 (Dcp-1Cl(2)mbn cells. Whereas Dcp-1FL was able to cleave in vitro translated Drice, a known target of Dcp-1 proteolytic activity, there were no detectable Hsp83 cleavage products (Fig. 3A).
Figure 3.

Hsp83 interacts with pro-Dcp-1 and suppresses its levels in a manner independent of transcriptional regulation. (A) Purified catalytically active Dcp-1 (Dcp-1FL) and catalytically inactive Dcp-1 (Dcp-1C

Hsp83 interacts with pro-Dcp-1 and suppresses its levels in a manner independent of transcriptional regulation. (A) Purified catalytically active Dcp-1 (Dcp-1FL) and catalytically inactive Dcp-1 (Dcp-1CDrice or Hsp83. Dcp-1FL cleaved Drice but not Hsp83. (B) N and C-terminal FLAG-tagged constructs of Hsp83 were expressed in l(2)mbn cells and immunoprecipitated with anti-FLAG antibodies. A representative western blot shows that both N- and C-FLAG-tagged constructs immunoprecipitated endogenous pro-Dcp-1 (Dcp-1 FL). No processed Dcp-1 was detected following immunoprecipitation. Similar results were observed in 3 independent experiments. (C) Dcp-1Cl(2)mbn cells and immunoprecipitated with anti-V5 antibodies. A representative western blot shows that Dcp-1CHsp83. Similar results were observed in 3 independent experiments. (D) Truncated Dcp-1CFLAG (tDcp-1CFLAG) was expressed in l(2)mbn cells and immunoprecipitated with anti-FLAG antibodies. A representative western blot (from n = 2 independent experiments) shows that tDcp-1 was unable to immunoprecipitate endogenous Hsp83. (E) Western blot of whole body lysates from females of the specified genotypes; pro-Dcp-1 = 35 kDa, ACTA/actin = 42 kDa. (F) Quantification of levels of pro-Dcp1 was determined by densitometry and normalized to levels of ACTA/actin. The average relative levels of pro-Dcp-1 were determined with 8 females per lysate (n = 3). Error bars represent ± SEM and statistical significance was determined by comparison to the w control using one-way ANOVA with a Dunnet post-test, *P < 0.05, **P < 0.01. (G) MSECs were scored as being positive or negative for cleaved Dcp-1 (clDcp-1). The average percentage was determined by analyzing over 50 MSECs per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined by comparison to w using one-way ANOVA with a Dunnet post-test, **P < 0.01,***P < 0.001. (H) Representative images of Drosophila ovarioles that were stained with cleaved Dcp-1 antibody and DAPI for w control and Hsp83, scale bars: 50 μm. (I) QRT-PCR was performed on mRNA extracts from 8 animals each to determine levels of Dcp-1 mRNA relative to the RP49 control mRNA (n = 3). The relative fold change was normalized to wild-type w with error bars representing ± SEM. There was no significant difference in Dcp-1 mRNA expression between genotypes. Because Dcp-1 does not cleave Hsp83, we reasoned that Hsp83 might be affecting Dcp-1 since chaperones stabilize proteins or facilitate their turnover. First, we investigated whether Hsp83 interacted with the full-length zymogen and/or the truncated active form of Dcp-1. Hsp83 and full-length Dcp-1 were confirmed to associate via affinity isolation assays using either Hsp83 or full-length Dcp-1CDcp-1 did not pull down Hsp83, indicating that the prodomain of Dcp-1 is required for its association with Hsp83 (Fig. 3D). We next quantified levels of the zymogen pro-Dcp-1 in Hsp83 flies by western blot analysis. Hsp83 and Hsp83 flies showed a significant increase in the levels of pro-Dcp-1 in comparison to wild type and the single alleles of Hsp83 (Fig. 3E, F). To determine if Hsp83 loss also led to elevated levels of catalytically active Dcp-1, we analyzed levels of cleaved Dcp-1 by scoring immunofluorescence. We found a statistically significant increase in the percentage of MSECS that stained positively for cleaved Dcp-1 in Hsp83 mutants compared with controls (Fig. 3G, H). The elevated levels of both pro-Dcp-1 and processed Dcp-1 indicate that loss of Hsp83 does not impair pro-Dcp-1 processing into its active form. To test the possibility of transcriptional regulation as a reason for the elevated Dcp-1, we performed qRT-PCR on RNA extracts from Hsp83 flies. We found that there was no significant difference in Dcp-1 transcript levels between Hsp83 transhets, Hsp83 heterozygote controls and wild type (Fig. 3I). These data suggest that loss of functional Hsp83 leads to increased Dcp-1 that is independent of transcriptional regulation. Next, we explored the potential role of the death-associated inhibitor of apoptosis 1 (Diap-1) protein. Diap1 was shown previously to ubiquitinate and inhibit the activity of cleaved Dcp-1 without affecting its levels, but the consequences on pro-Dcp-1 levels are unknown. We overexpressed Diap1 in vivo and found that Diap1 overexpression did not have a significant effect on the protein levels of pro-Dcp-1 (Fig. S4A, B). We also overexpressed Diap1 in the Hsp83 transhet background and found no statistically significant difference in levels compared with the Hsp83 transhets (Fig. S4C, D). These results, together with the association of Hsp83 with only the zymogen form of Dcp-1, indicate that the regulation of pro-Dcp-1 levels in this context is largely independent of Diap-1.

Hsp83 mutants have reduced proteasomal activity

Orthologs of Hsp83, yeast Hsc82 and Hsp82 (orthologs of mammalian HSP90α and HSP90β, respectively), and human HSP90α, are needed for 26S proteasomal assembly respectively in yeast and in humans for antigen processing., To test whether altered proteasomal activity could be a possible explanation for the elevated levels of Dcp-1 observed in Hsp83 mutants, we used a luminescence assay with proteasome-targeted substrates that react when cleaved. Luminescence was significantly decreased in flies harboring RNAi targeting Prosα1, a subunit of the 20S proteasome, and in Hsp83 transhets when compared with Hsp83 heterozygote controls and wild-type flies (Fig. 4A). To confirm the decreased proteasome activity in Hsp83 transhets, we expressed the proteasome activity reporter CL1-GFP, a fusion protein with a degradation signal introduced into the otherwise stable GFP molecule, in the larval fat body using the larval midgut specific driver cg-GAL4. The Hsp83 transhets had a marked increase in GFP expression relative to controls, indicating inefficient turnover of CL1-GFP (Fig. 4B, C). The observed reduction in proteasomal activity could explain why Dcp-1 levels are elevated in the Hsp83 transhet mutants.
Figure 4.

Loss of Hsp83 decreases proteasomal activity resulting in elevated Dcp-1 levels. (A) Proteasomal activity was measured in females from the indicated genotypes using luminescent output (RLU) produced from cleavage of proteasomal substrates (ProteasomeGlo kit) and made relative to mass. Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Bonferroni post-test and compared with w, *P < 0.05, **P < 0.01. (n = 5) (B, C) UAS-CL1-GFP expressed in the larval fat body using the driver cg-GAL4 and visualized with nonadjusted GFP channel images taken in the same experiment with identical confocal microscope settings (n = 3). (B) Representatives images, scale bars: 50 μm and (C) quantification of fluorescence intensity using mean fluorescent intensity (MFI). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, ****P < 0.0001. (D, E) Females with the maternal driver nosGAL4 were collected after 2 d of exposure to 18°C or 25°C with the genotypes +/UAspDcr-2; nosGAL4/+ (Dcr-2) and Rpn2-RNAI/UAspDcr-2;nosGAL4/+ (Rpn2/Dcr-2). (D) Representative western blot of pro-Dcp-1 and ACTA/actin levels in Dcr-2 and Rpn2/Dcr-2 pro-Dcp-1 = 35 kDa, ACTA/actin = 42 kDa, * represents a nonspecific band detected by the Dcp-1 antibody. (E) Quantification of pro-Dcp-1 levels was performed by densitometry and normalized to levels of ACTA/actin. The average relative levels of pro-Dcp-1 were determined with 8 females per lysate (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-way Student t test, **P < 0.01. (F) to H) Hsp83 and w flies were fed proteasomal inhibitor MG132 or the control DMSO for 4 d. (F) Proteasomal activity was measured and normalized to w flies fed with DMSO (n = 3). Error bars represent ± SEM and statistical significance was determined using a Student t test, *P < 0.05, **P < 0.01, ***P < 0.001. (G) Representative image of a western blot probed for pro-Dcp-1(35 kDa) and TUBB/tubulin (55 kDa). (H) Quantification of pro-Dcp-1 levels was performed by densitometry and normalized to levels of TUBB/tubulin. The average relative levels of pro-Dcp-1 were determined with 8 females per lysate (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-way Student t test, *P < 0.05, **P < 0.01, ***P < 0.001.

Loss of Hsp83 decreases proteasomal activity resulting in elevated Dcp-1 levels. (A) Proteasomal activity was measured in females from the indicated genotypes using luminescent output (RLU) produced from cleavage of proteasomal substrates (ProteasomeGlo kit) and made relative to mass. Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Bonferroni post-test and compared with w, *P < 0.05, **P < 0.01. (n = 5) (B, C) UAS-CL1-GFP expressed in the larval fat body using the driver cg-GAL4 and visualized with nonadjusted GFP channel images taken in the same experiment with identical confocal microscope settings (n = 3). (B) Representatives images, scale bars: 50 μm and (C) quantification of fluorescence intensity using mean fluorescent intensity (MFI). Error bars represent ± SEM and statistical significance was determined using a 2-tailed Student t test, ****P < 0.0001. (D, E) Females with the maternal driver nosGAL4 were collected after 2 d of exposure to 18°C or 25°C with the genotypes +/UAspDcr-2; nosGAL4/+ (Dcr-2) and Rpn2-RNAI/UAspDcr-2;nosGAL4/+ (Rpn2/Dcr-2). (D) Representative western blot of pro-Dcp-1 and ACTA/actin levels in Dcr-2 and Rpn2/Dcr-2 pro-Dcp-1 = 35 kDa, ACTA/actin = 42 kDa, * represents a nonspecific band detected by the Dcp-1 antibody. (E) Quantification of pro-Dcp-1 levels was performed by densitometry and normalized to levels of ACTA/actin. The average relative levels of pro-Dcp-1 were determined with 8 females per lysate (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-way Student t test, **P < 0.01. (F) to H) Hsp83 and w flies were fed proteasomal inhibitor MG132 or the control DMSO for 4 d. (F) Proteasomal activity was measured and normalized to w flies fed with DMSO (n = 3). Error bars represent ± SEM and statistical significance was determined using a Student t test, *P < 0.05, **P < 0.01, ***P < 0.001. (G) Representative image of a western blot probed for pro-Dcp-1(35 kDa) and TUBB/tubulin (55 kDa). (H) Quantification of pro-Dcp-1 levels was performed by densitometry and normalized to levels of TUBB/tubulin. The average relative levels of pro-Dcp-1 were determined with 8 females per lysate (n = 3). Error bars represent ± SEM and statistical significance was determined using a 2-way Student t test, *P < 0.05, **P < 0.01, ***P < 0.001.

Reduction in proteasomal activity leads to an increase in Dcp-1

To determine if Dcp-1 levels are affected by the proteasome, we quantified levels of Dcp-1 in an RNAi line targeted against Rpn2, a regulatory subunit of the 26S proteasome. RNAi knockdown was enhanced by expressing one copy of Dcr-2/Dicer2 using the oogenesis-specific driver nosGAL4. An increase in temperature enhances expression of GAL4-driven Dcr-2 under the UAsp promoter and thus the knockdown is more efficacious. Rpn2 RNAi flies (Rpn2/Dcr-2) or control flies (Dcr-2), were incubated at 18°C or 25°C for 2 d before collection. The enhanced knockdown of Rpn2 at 25°C correlated with a greater increase in pro-Dcp-1 levels in comparison to the Dcr-2 flies (Fig. 4D, E). In addition to genetic suppression of the proteasome, we tested pharmacological inhibition by feeding flies the proteasome inhibitor MG132. A significant decrease in proteasomal activity was observed in both wild type and Hsp83 transhets following MG132 treatment (Fig. 4F). The levels of pro-Dcp-1 increased in wild type with the addition of MG132, consistent with the decrease in proteasomal activity (Fig. 4G, H). There was no further increase in the levels of pro-Dcp-1 in Hsp83 transhets treated with MG132 compared with the DMSO control despite reduced proteasomal activity. Together, these results show that Dcp-1 levels are affected by the proteasome and that the reduction of Dcp-1 is dependent on functional Hsp83.

Hsp83 loss induces Dcp-1-dependent compensatory autophagy that is required to maintain female fertility and larval viability

We previously found that Dcp-1 levels are increased and induce autophagic flux in response to starvation., To understand if the increased levels of autophagy in Hsp83 mutants are dependent on Dcp-1, we performed an epistasis experiment. We constructed double mutants consisting of Hsp83 transhets and the Dcp-1 loss-of-function alleles. Ovaries from Dcp-1 flies contain persisting nurse cell nuclei and premature loss of follicle cells. We found the MSECs of double mutants Dcp-1 and Dcp-1 flies have a phenotype similar to Dcp-1 but with several differences (Fig. 5A, B). The MSECs appear to have a premature loss of follicle cells, similar to Dcp-1 flies, but the nurse cell nuclei are only partially condensed relative to those observed in MSDECs from Hsp83 transhet mutants. The nurse cell nuclei in Hsp83; Dcp-1 double-mutant MSECs also stain positively for TUNEL similar to Hsp83, however, fail to stain for LTR.
Figure 5.

Dcp-1 is required for autophagic flux but not cell death resulting from loss of Hsp83. (A,B) Representative images of MSECs for the genotypes w and Dcp-1; Hsp83, stained with (A) LTR and DAPI or (B) LTR and TUNEL; experiments were performed on at least 8 females per genotype (n = 3), scale bars: 50 μm. (C)Representative images of first in-star larval fat bodies stained with LTR, DAPI and TUNEL; scale bars:10 μm. (D) Quantification of the total number of cells, determined by DAPI staining, that stained positively for LTR and/or TUNEL in larval fat bodies from listed genotype. Experiments were performed in triplicate with the total number of cells assessed listed in the table. (E) The ratio of dead pharate adult pupae to eclosed pupae was counted in vials containing different combinations of mutant Hsp83 and Dcp-1 alleles. Vials were incubated at room temperature for 14 d past first fly eclosion and then ratios were counted for at least 80 animals (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test (**P < 0.01). (F, G) The number of autolysosomes per cell was quantified in S2 cells stably expressing GFP-RFP-Atg8a and treated with the indicated dsRNAs. (F) All counts were normalized to the Amp dsRNA control. Atg1 and Rheb dsRNA's served as controls for decreasing and increasing the number of autolysosomes, respectively (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test, *P < 0.05, **P < 0.01,***P < 0.001. More than 100 cells were analyzed per treatment. (G) Representative images of GFP-RFP-Atg8a S2 cells following treatment with the indicated dsRNAs; scale bars:10 μm.

Dcp-1 is required for autophagic flux but not cell death resulting from loss of Hsp83. (A,B) Representative images of MSECs for the genotypes w and Dcp-1; Hsp83, stained with (A) LTR and DAPI or (B) LTR and TUNEL; experiments were performed on at least 8 females per genotype (n = 3), scale bars: 50 μm. (C)Representative images of first in-star larval fat bodies stained with LTR, DAPI and TUNEL; scale bars:10 μm. (D) Quantification of the total number of cells, determined by DAPI staining, that stained positively for LTR and/or TUNEL in larval fat bodies from listed genotype. Experiments were performed in triplicate with the total number of cells assessed listed in the table. (E) The ratio of dead pharate adult pupae to eclosed pupae was counted in vials containing different combinations of mutant Hsp83 and Dcp-1 alleles. Vials were incubated at room temperature for 14 d past first fly eclosion and then ratios were counted for at least 80 animals (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test (**P < 0.01). (F, G) The number of autolysosomes per cell was quantified in S2 cells stably expressing GFP-RFP-Atg8a and treated with the indicated dsRNAs. (F) All counts were normalized to the Amp dsRNA control. Atg1 and Rheb dsRNA's served as controls for decreasing and increasing the number of autolysosomes, respectively (n = 3). Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test, *P < 0.05, **P < 0.01,***P < 0.001. More than 100 cells were analyzed per treatment. (G) Representative images of GFP-RFP-Atg8a S2 cells following treatment with the indicated dsRNAs; scale bars:10 μm. To determine if the relationship between Hsp83 and Dcp-1 occurs in other tissues we analyzed the larval fat body. The larval fat body is also a good model for monitoring autophagy as it is sensitive to oxidative stress and starvation., Fat bodies from Hsp83 transhets had increased TUNEL and LTR staining, similar to the ovaries. In addition, fat bodies from Dcp-1;Hsp83 double mutants had only TUNEL staining whereas control Hsp83 alleles, Dcp-1 and wild-type flies had no significant LTR or TUNEL (Fig. 5C, D). The Hsp83;Dcp-1 double mutants also affected fecundity as both females and males were sterile whereas only male Hsp83 transhets are sterile and Dcp-1 flies are fertile. In addition, the double mutants showed a reduction in viability with a significant increase in the fraction of animals dying in the pharate adult stage and not being able to eclose, as quantified by the ratio of dead pharate adults to eclosed pupae (P < 0.01) (Fig. 5E). These results suggest that loss of Hsp83 can lead to activation of cell death through a pathway independent of Dcp-1, but that loss of Hsp83 induces compensatory autophagy through a pathway that requires Dcp-1. To further validate the relationship between Hsp83 and Dcp-1, we conducted RNAi studies in the S2-GFP-RFP-Atg8a cell line as a more specific autophagy assay. As expected, Atg1 and Rheb showed a relative decrease and increase in the numbers of autolysosomes, respectively, compared with the control (Fig. 5F, G). The decrease in autolysosomes seen in the Dcp-1 RNAi-treated cells was reiterated in the double knockdown of Hsp83 and Dcp-1 and was in stark contrast to the increase observed in Hsp83 RNAi-treated cells.

Proteasome disruption induces Dcp-1-dependent compensatory autophagy

To determine if Dcp-1 is required for compensatory autophagy following proteasome disruption specifically we used RNAi targeted against Rpn11, a Drosophila proteasome regulatory subunit, that was shown to compromise proteasomal activity. Similar to Hsp83-RNAi, the Rpn11-RNAi resulted in enhanced levels of autolysosomes that were significantly reduced in combination with Dcp-1 RNAi (Fig. 6A, B). Since mutant Hsp83 transhets showed an increase in pro-Dcp-1, cleaved Dcp-1, and LTR staining, we investigated whether there was also an increase in cleaved Dcp-1 and LTR staining in proteasome-compromised flies in addition to the elevated pro-Dcp1 levels already observed (Fig. 4D, E). Rpn2/Dcr-2 flies kept at 25°C showed a significant increase in the number of MSDECs expressing cleaved Dcp-1 that were LTR positive (Fig. 6C, D). To determine if LTR levels correlated with Dcp-1 levels, we quantified staining at both 18°C and 25°C, and found a significant increase (P < 0.05) in LTR staining, along with increased Dcp-1 levels, at the higher temperature (Fig. 6E). Together, these findings support that the increase in autophagy detected in vitro and in vivo in response to reduced proteasome function is regulated by Dcp-1.
Figure 6.

Proteasomal subunit loss results in Dcp-1-dependent compensatory autophagy. (A, B) The number of autolysosomes per cell was quantified in S2 cells stably expressing GFP-RFP-Atg8a and treated with the indicated dsRNAs. (A) Representative images of GFP-RFP-Atg8a S2 cells following treatment with the indicated dsRNAs; scale bars: 10 μm. (B) All counts were normalized to the Amp dsRNA control. Atg1 and Rheb dsRNA's served as controls for decreasing and increasing the number of autolysosomes, respectively. Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test, *P < 0.05, **P < 0.01,***P < 0.001 (C, D) Females were collected from flies with the UAS maternal driver kept at 25°C with the genotypes UAspDcr-2/+; nosGAL4/+ (Dcr-2) and Rpn2-RNAI/UAspDcr-2;nosGAL4/+ (Rpn2/Dcr-2). (C) Representative images of MSECs from Rpn2/Dcr-2 and Dcr-2 kept at 25°C. Ovaries were imaged with clDcp-1 antibody, LTR and DAPI; scale bars: 50 μm. (D) MSECS from Dcr-2 and Rpn2/Dcr-2 flies were scored for cleaved Dcp-1 (clDcp-1), LTR and DAPI. The graph represents the average percentage of MSECs that scored positive for LTR, MSDEC or clDcp-1. Experiments were performed with at least 8 females per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using the 2-way Student t test, *P < 0.05, **P < 0.01 (E) MSECS in Rpn2/Dcr-2 flies were scored for LTR positivity at 18°C and 25°C. At least 50 MSECS were analyzed per temperature (n = 4). Error bars represent ± SEM and statistical significance was determined using the 2-way Student t test, *P < 0.05 (F) A proposed pathway indicating that Hsp83 functions in basal conditions to contribute to proteasomal activity which suppresses pro-Dcp-1 levels and thus prevents activation of autophagy or cell death.

Proteasomal subunit loss results in Dcp-1-dependent compensatory autophagy. (A, B) The number of autolysosomes per cell was quantified in S2 cells stably expressing GFP-RFP-Atg8a and treated with the indicated dsRNAs. (A) Representative images of GFP-RFP-Atg8a S2 cells following treatment with the indicated dsRNAs; scale bars: 10 μm. (B) All counts were normalized to the Amp dsRNA control. Atg1 and Rheb dsRNA's served as controls for decreasing and increasing the number of autolysosomes, respectively. Error bars represent ± SEM and statistical significance was determined using one-way ANOVA with a Dunnet post-test, *P < 0.05, **P < 0.01,***P < 0.001 (C, D) Females were collected from flies with the UAS maternal driver kept at 25°C with the genotypes UAspDcr-2/+; nosGAL4/+ (Dcr-2) and Rpn2-RNAI/UAspDcr-2;nosGAL4/+ (Rpn2/Dcr-2). (C) Representative images of MSECs from Rpn2/Dcr-2 and Dcr-2 kept at 25°C. Ovaries were imaged with clDcp-1 antibody, LTR and DAPI; scale bars: 50 μm. (D) MSECS from Dcr-2 and Rpn2/Dcr-2 flies were scored for cleaved Dcp-1 (clDcp-1), LTR and DAPI. The graph represents the average percentage of MSECs that scored positive for LTR, MSDEC or clDcp-1. Experiments were performed with at least 8 females per genotype (n = 3). Error bars represent ± SEM and statistical significance was determined using the 2-way Student t test, *P < 0.05, **P < 0.01 (E) MSECS in Rpn2/Dcr-2 flies were scored for LTR positivity at 18°C and 25°C. At least 50 MSECS were analyzed per temperature (n = 4). Error bars represent ± SEM and statistical significance was determined using the 2-way Student t test, *P < 0.05 (F) A proposed pathway indicating that Hsp83 functions in basal conditions to contribute to proteasomal activity which suppresses pro-Dcp-1 levels and thus prevents activation of autophagy or cell death.

Discussion

In this study we identified 13 putative negative autophagy regulators that could be involved in Dcp-1-mediated regulation of autophagy via an IAP and MS-MS, and flow cytometry screen. Of those interactors, we further characterized the role of Hsp83 and found that it negatively regulates autophagy and cell death in Drosophila in vivo and in vitro. Hsp83 was found to interact with the zymogen pro-Dcp1, and loss of Hsp83 function led to a decrease in proteasomal activity and an increase in Dcp-1 that was not transcriptionally regulated. Analysis of proteasome-compromised flies also showed an increase in levels of Dcp-1 and LTR staining supporting that Dcp-1 is regulated by the proteasome. The Dcp-1 observed in Hsp83 mutants was found to be required for the ensuing compensatory autophagy, and contributed to both female fertility and development to adulthood. These findings highlight a novel role for Hsp83 in the proteasome-dependent regulation of pro-Dcp-1 that functions normally to prevent activation of autophagy (Fig. 6F).

Putative Dcp-1 interactors identified

It is possible that the 11 additional proteins identified in the IAP-MS/MS study may also positively or negatively regulate autophagy, but due to potential incomplete knockdown by RNAi or functional redundancy did not show an autophagy phenotype. Further in vivo studies to validate the remaining genes identified in the RNAi screen for their autophagy-regulatory role during Drosophila oogenesis or in other tissues will be valuable. It will be important to identify potential Dcp-1 cleavage substrates as it has been found that Dcp-1 catalytic activity is required to activate autophagy.

pro-Dcp-1 levels are regulated by the proteasome

Caspases require constitutive regulation to prevent unwanted activation and cell death. Inhibitor of apoptosis proteins are one way caspases can be regulated, acting either through baculovirus inhibitor of apoptosis protein repeat (BIR) domain binding or E2-E3 ubiquitin ligase activity which can be degradative or nondegradative. While the active (cleaved) form of Dcp-1 is regulated by Diap1 through nondegradative ubiquitination, it was unknown how or if the zymogen form of Dcp-1 is regulated. We found that the elevated levels of pro-Dcp-1 in Hsp83 mutants neither correspond to Diap1 levels nor to transcript levels. Instead, we found that pro-Dcp-1 levels were elevated following the loss of function of Hsp83, 2 different proteasomal subunits or pharmacological inhibition of the proteasome. While other Drosophila caspases, Drice and Dronc, were found not to be stabilized by proteasome inhibition,,, there is precedence for proteasome regulation of the cleaved form, but not the proform, of CASP8 and CASP3 in human cell lines., Based on our protein interaction studies that showed Hsp83 only interacts with the proform of Dcp-1, we propose a model where Hsp83 acts at a relatively early stage, before Diap1, to regulate levels of pro-Dcp-1 via the proteasome in basal conditions. Functional loss of Hsp83 results in elevated pro-Dcp-1 that is available for the subsequent cleavage into active Dcp-1 and the induction of autophagy. Further studies are required to determine if pro-Dcp-1 itself is being directly processed by the proteasome or is instead indirectly regulated by the proteasome through as of yet unknown molecular components. Another outstanding question is the threshold of Dcp-1 required for autophagy induction.

Hsp83 mediates proteasomal degradation

It has been shown previously that Hsp83 plays a role in promoting protein degradation involving a degradative complex function. Loss of Hsp83 leads to a build-up of proteins targeted for degradation in the cell cycle due to inhibition of the anaphase-promoting complex/cyclosome. In a Drosophila neurodegenerative disease model, Hsp83 is required for targeting the mutant protein TPI for proteasomal degradation, and, similarly, the human ortholog HSP90 is required for the delivery of substrates to the proteasome. While proteasomal activity was further decreased in Hsp83 transhets treated with MG132, the level of pro-Dcp-1 was not further increased, suggesting that Hsp83 specifically is a rate-limiting step in the proteasomal processing of pro-Dcp-1. However, it is still unknown if the physical interaction between pro-Dcp-1 and Hsp83 is ultimately important for proteasomal regulation of pro-Dcp-1, or if Hsp83 acts indirectly to control pro-Dcp-1 levels by promoting proteasomal activity. Since Hsp83 and pro-Dcp-1 could have been immuno-affinity purified in a complex involving the proteasome, further work is required to understand if pro-Dcp-1 requires Hsp83 for delivery or targeting to the proteasome or if Hsp83 might play a more direct role at the proteasome to facilitate degradation of pro-Dcp-1.

Dcp-1 regulates compensatory autophagy

Proteostasis requires a balance between the 2 major degradative UPS and autophagy pathways. When proteasome activity is inhibited, as is the case in Hsp83 mutants, there is increased autophagic flux known as compensatory autophagy. Previous to this study, Dcp-1 is reported to be a positive regulator of autophagy only in the context of starvation although overexpression also induces autophagy.,, Here, we observed a Dcp-1 dependent increase in the number of autolysosomes or lysosomal staining with loss of Hsp83 or Rpn11, and thus reduced proteasomal activity, even in nutrient-rich conditions. In fly models compensatory autophagy occurs when the UPS is inhibited,, but this is the first time an effector caspase has been reported to be involved. The discovery that Dcp-1 is required for compensatory autophagy when proteasomal activity is compromised begs further exploration into whether there are other forms of stresses or contexts, such as hypoxia, that also rely on Dcp-1 for autophagy induction.

Hsp83;Dcp-1 double mutants have effects on cell death, cell division, autophagy, fertility and development

Loss of Dcp-1 prevents the autophagy that is otherwise induced in loss-of-function Hsp83 mutants, indicating a Dcp-1-dependent role in the regulation of autophagy in this context. In addition to autophagy dysregulation, double Dcp-1;Hsp83 mutants had other surprising phenotypes involving cell death and division. Dcp-1;Hsp83 flies had an abnormal number of persisting nurse cell nuclei that showed partial condensation and stained positively for TUNEL. This suggests that the cell death associated with Hsp83 loss is Dcp-1-independent and that Dcp-1 contributes at least partially to the pyknosis observed. The double mutants also rendered females sterile and did not rescue the male sterility observed in Hsp83 mutants, indicating an increasingly impaired phenotype. Furthermore, there was an increase in animals with developmental defects as more flies mutant with Hsp83 and Dcp-1 flies died in the pharate adult stage. This divergence between control of cell death and autophagy with Dcp-1 and Hsp83 is a unique and surprising finding. Discovery of this relationship provides a potential avenue for further understanding the complex cross-talk between autophagy and apoptosis, as well as for exploitation of promoting cell death without autophagy by counterintuitively targeting an effector caspase in the presence of Hsp83/HSP90 genetic or pharmacologic inhibition. In summary, our Dcp1-related IAP-MS/MS strategy followed by an in vitro RNAi screen resulted in the identification of several novel regulators of autophagy and provides a foundation for further in vivo analyses. Further investigation into one of the interactors, Hsp83, led to the identification of its role not only in maintaining proteasomal activity but also suppressing autophagy through the maintenance of low levels of pro-Dcp-1. Understanding the role Hsp83 and its orthologs play is important as HSP90 plays a prominent role in cancer and neurodegeneration.,, The knowledge that inhibition of HSP90 function can affect proteasomal activity and induce compensatory autophagy is particularly pertinent as HSP90 is currently a drug target under trial for these diseases., Additionally, the proteasome is inhibited by the drug bortezomib for treatment of cancers such as multiple myeloma and mantle cell lymphoma and has been shown to induce autophagy in melanomas., The identification of a caspase being responsible for the regulation of compensatory autophagy could be conserved in humans and is an important avenue for future investigation. This study highlights the discovery of a previously unidentified proteostatic relationship in Drosophila between Hsp83 and Dcp-1 in vivo.

Materials and methods

Fly strains

w was used as the wild-type control strain in this study. A complete list of stocks can be found in Table 2. All flies were collected in nutrient-rich conditions at room temperature unless otherwise stated.
Table 2.

Drosophila stock list.

GenotypeDescriptionSource
Hsp83e6A/TM6Bpoint mutation in Hsp83 gene causing amino acid replacement: S592FBloomington Stock Center (Stock number 36576)
Hsp83e6D/TM6Bpoint mutation in Hsp83 gene causing amino acid replacement: E317KBloomington Stock Center (Stock number 5696)
Hsp836–55/TM6Bpoint mutation in Hsp83 gene causing amino acid replacement: P380SB. Edgar (Heidelberg University, Heidelberg, Germany).21
Dcp-1Prev1contains a 40-bp partial P element insertion in the coding region of Dcp-1, resulting in an in-frame stopK. McCall (Boston University, Boston, MA)20
UASp-GFP-mCherry-Atg8aExpression of GFP-mCherry-Atg8a under the UASp promoterT.E. Rusten (Center for Cancer Biomedicine, Oslo University Hospital, Montebello, Oslo, Norway)18
UAS-Dcr-2; nosGAL4Female germline driver and construct of Dcr-2/Dicer-2 driven under the UAS promoterBloomington Stock Center (Stock number 25751)
20ProtS-GDRNAi strain targeted against the gene encoding proteasomal subunit Prosα1Vienna Drosophila Resource Center (transformant ID 49681)
Rpn2-KKRNAi strain targeted against the gene encoding regulatory proteasomal subunit Rpn2Vienna Drosophila Resource Center (transformant ID 106457)
MTD-Gal-4Maternal triple driver used for crossesBloomington Stock Center (Stock number 31777)
sco/CyO;TM6B/MKRSBalancer stock used for crossesBloomington Stock Center (Stock number 3703)
UASt-CL1-GFPExpression of CL1-GFP under the UASt promoterU. Pandey (Children's Hospital of Pittsburgh, University of Pittbursgh Medical Center, Pittsburgh, PA)5
Cg-GAL4GAL4 driver in hemocytes, fat body and lymph gland used for larval fat body experimentsBloomington Stock Center (Stock number 7011)
UASp-Diap1.PExpression of Diap1 under the UASp promoterBloomington Stock Center (Stock number 63820)
Drosophila stock list.

Cell culture

Drosophila l(2)mbn cells were grown in Schneider medium (Invitrogen, 11720–034) supplemented with 10% fetal bovine serum in 25-cm2 suspension cell flasks (Sarstedt, 83.1810.502) at 25°C. Drosophila S2-GFP-RFP-Atg8a cells were grown in ESF921 medium (Expression Systems, 96–001–01) in 25-cm2 suspension cell flasks at 25°C and treated with 50 μg/mL Zeocin (Invitrogen, R250–01). All experiments were performed 3 to 4 d after passage of cells.

Immuno-affinity purification (IAP) and MS/MS analysis

A detailed protocol for the IAP and MS/MS is described in a previous paper. Putative interacting proteins were identified by having an X!Tandem log(e) score less than −3 and were identified in at least 2 experimental samples (V5–Dcp-1C

dsRNA synthesis and RNAi

Each PCR primer for RT-PCR was designed to contain a 5’ T7 RNA polymerase-binding site (TAATACGACTCACTATAGG) followed by sequences specific for the target gene. The ampicillin resistance gene was used as a control dsRNA. The PCR products were generated by RT-PCR using Superscript one-step RT-PCR with Platinum Taq (Invitrogen). RT-PCR products were ethanol precipitated and used as a template for in vitro transcription reactions using T7 RiboMax Express RNAi systems (Promega). Quality of the RNA was analyzed by gel electrophoresis. dsRNA was quantified using PicoGreen and adjusted to 200 to 400 ng/μL with nuclease-free water. PCR primers for dsRNA synthesis are listed in Table 3.
Table 3.

Sets of primers used for dsRNA synthesis.

GeneForward Primer Sequence (5′-3′)Reverse Primer Sequence (5′-3′)
1st set
14–3–3εTAATACGACTCACTATAGGGACAGGTGGAGAAGGAGCTGTAATACGACTCACTATAGGTCAGTGTATCCAACTCGGCA
14–3–3ζTAATACGACTCACTATAGGGTCACAGAGACTGGCGTTGATAATACGACTCACTATAGGCGTAGCAGATTTCCCTCAGC
ATPsynβTAATACGACTCACTATAGGCGTCGATGTCCAGTTTGATGTAATACGACTCACTATAGGTGATGCGTCCTAGTGTTTCG
blwTAATACGACTCACTATAGGTGTGTTCTACCTGCATTCGCTAATACGACTCACTATAGGCACGTACTGACCCTGCTTGA
CCT2TAATACGACTCACTATAGGGTGGACAACATCATCCGTTGTAATACGACTCACTATAGGCAGCACTCATCCTCGAATCA
ClicTAATACGACTCACTATAGGTTCCGTACCAATTTTGAGGCTAATACGACTCACTATAGGATCAGCTCACAGTCGAAGCA
eEF1α1TAATACGACTCACTATAGGGTGACTCCAAGGCTAACCCCTAATACGACTCACTATAGGTTAGAGGGCACCAGGTTGAC
eEF1βTAATACGACTCACTATAGGGAAGTCTAAGAAACCCGCCCTAATACGACTCACTATAGGTGCTTAGTTCGCTTTGCTCA
eEF1γTAATACGACTCACTATAGGGGTGTTCATGTCGTGCAATCTAATACGACTCACTATAGGGAAGATCTTGCCCTGGTTGA
eIF4ATAATACGACTCACTATAGGTTACGTCAACGTGAAGCAGGTAATACGACTCACTATAGGAATGTAGTTCTCGCGGTTCG
Hsp60ATAATACGACTCACTATAGGCACCCTCACCGATATGGCTAATACGACTCACTATAGGGGGTGTCGTCCTTGGTGA
Hsc70–4TAATACGACTCACTATAGGATCTGACCACCAACAAGCGTTAATACGACTCACTATAGGATGACCGACTTGTCCAGCTT
Hsp70AaTAATACGACTCACTATAGGGGGAGGATTTGGAGGCTACTTAATACGACTCACTATAGGTCGATCGAAACATTCTTATCAGTC
Hsc70CbTAATACGACTCACTATAGGGAAAAACACAGTTGGCGGATTAATACGACTCACTATAGGGGTCTTGGCGTTGATCTTGT
Hsp83(1)TAATACGACTCACTATAGGGAGCTGAACAAGACCAAGCCTAATACGACTCACTATAGGTTGCGGATCACCTTTAGGAC
Jafrac1TAATACGACTCACTATAGGATGGAGTGCTCGATGAGGAGTAATACGACTCACTATAGGTACTCCTTGGACTTGGTGGG
Mi-2TAATACGACTCACTATAGGCGCAAGTACGACATGGAAGATAATACGACTCACTATAGGTCGACCTTGAGCTTGGACTT
Rack1TAATACGACTCACTATAGGACCTCAATGACGGCAAGAACTAATACGACTCACTATAGGATTTGACGCCCGTTACAAAG
REGTAATACGACTCACTATAGGCCATTCAAGAGGACACGCTTTAATACGACTCACTATAGGACAAGAATTGCTGACCGTCC
sesBTAATACGACTCACTATAGGCTGATACTGGCAAGGGTGGTTAATACGACTCACTATAGGCCCAGCTGATGTAGATGGGT
sglTAATACGACTCACTATAGGAATCTCCAGCATCAATTCGCTAATACGACTCACTATAGGAACAAACTCATCCCACTCCG
staTAATACGACTCACTATAGGAGTTCGCCAAGTACACCGACTAATACGACTCACTATAGGGGATCGCGGTAGAAGAACAG
TER94TAATACGACTCACTATAGGCATGGGAGCCAAGAAGAATGTAATACGACTCACTATAGGGTCACCTTGGCGATGTAGGT
Uba1TAATACGACTCACTATAGGGATTTCGCAAAGCTGGACTCTAATACGACTCACTATAGGTAGGCTTCTGCACATCATGC
2nd set
ATPsynβTAATACGACTCACTATAGGCTCCTGGCTCCATACGCTAATACGACTCACTATAGGATATGGCCTGAACAGAAGTAAT
blwTAATACGACTCACTATAGGGTACTGCATCTACGTCGCCATAATACGACTCACTATAGG ACGTTGGTTGGAATGTAGGC
ClicTAATACGACTCACTATAGGATCAGCCTGAAGGTGACGACTAATACGACTCACTATAGGACAGGTTCTCGATCAGGGTG
eIF4ATAATACGACTCACTATAGGTCGATTGCTATCCTTCAGCATAATACGACTCACTATAGGGATCTGATCCTTGAAACCGC
Hsp60ATAATACGACTCACTATAGGGGGAGGGAGATGTGATGAGATAATACGACTCACTATAGGGCGAAGCAAAACAAAGTTCC
Hsc70–4TAATACGACTCACTATAGGGGCTGACAAGGAGGAGTACGTAATACGACTCACTATAGGTGTCGTTTGACCCGTTTGTA
Hsp70AaTAATACGACTCACTATAGGCCCACTTTCATTGGGAATTGTAATACGACTCACTATAGGAATGCATTGTTGTCCTTCGTC
Hsp83(2)TAATACGACTCACTATAGGATTGCTCAGCTGATGTCCCTTAATACGACTCACTATAGGGGAGTAGAAACCCACACCGA
Mi-2TAATACGACTCACTATAGGATTTGCGTGGTAAATCGGAGTAATACGACTCACTATAGGGTTCTTGCTTCACCTCGCTC
REGTAATACGACTCACTATAGGGTTGATCCTCAAGGCAGAGCTAATACGACTCACTATAGGTCCTCCACAAGCTTCCTGAT
sesBTAATACGACTCACTATAGGGCAAGAACCCTTCCTTCCTCTAATACGACTCACTATAGGTTCGGAGGCGAAAGAATCTA
staTAATACGACTCACTATAGGTTTCCACGTTAACATGTCGGTAATACGACTCACTATAGGCCCAGGTTGAGGATGTTGAC
TER94TAATACGACTCACTATAGGGCATGATGATGTTGACCTGGTAATACGACTCACTATAGGCTGCATGCCAAACTTCAAGA
Additional primer sets
Hsp83ATAATACGACTCACTATAGGAAATCCCTGACCAACGACTGTAATACGACTCACTATAGGTTGCGGATCACCTTTAGGAC
Hsp83BTAATACGACTCACTATAGGGAGCTGAACAAGACCAAGCCTAATACGACTCACTATAGGGAGTCGACCACACCCTTCAT
Rpn11TAATACGACTCACTATAGGCTGCTACGTCTTGGAGGTGCTATGCCACAGGTAATACGACTCACTATAGGACAGTGCTCATTGTAGTCGGACAACGTGAGGC
Sets of primers used for dsRNA synthesis. l(2)mbn cells and S2-GFP-RFP-Atg8a were washed and resuspended in ESF921 medium (Expression Systems, 96–001–01) to a concentration of 2 × 106 cells/mL. Cells (333 μL for 24-well plates or 1 mL for 6-well plates) were plated. dsRNAs were added at 10 μg (for 24-well plates) or 30 μg (for 6-well plates) per well and incubated at 25°C for 1 h. Following incubation, 667 μL (for 24-well plates) or 2 mL (for 6-well plates) of Schneider medium + 10% FBS was added back to each well and incubated for an additional 72 h at 25°C. S2-GFP-RFP-Atg8a cells were transferred to an 8-well Chamber Slide (Thermo Fisher Scientific, 154941) overnight and the next d treated with a second dose of dsRNAs in E2F921 for 7 h before fixation. Puncta were either counted manually from saved microscopy images or automatically by using a contours discovery algorithm in OpenCV Python package as described in, was applied to images preprocessed by filtering colors and applying a Gaussian filter and adaptive threshold. For LTG (Invitrogen, L-7526) experiments for flow cytometry, 66 μL of 2 × 106 cells/mL were plated in triplicate in a 96-well plate and analyzed on a BD FACSCalibur™ (BD Biosciences, San Jose, CA USA). dsRNA (10 μg) was added per well and incubated for 1 h at room temperature. Schneider medium + 10% FBS (134 μL) was added back to each well and incubated for 72 h at 25°C. Cells were then treated with a second dose of dsRNAs in ESF921 for 7 h before analysis.

Immunofluorescence studies and microscopy

Flies were conditioned on wet yeast paste for 2 d before dissection. Ovaries were dissected in phosphate-buffered saline (PBS; Sigma, P3813) and fixed with 4% paraformaldehyde. Flies expressing fluorescent reporters were then mounted with Slowfade Gold Antifade Reagent with DAPI (Invitrogen, S36939). Fluorescence intensity for the CL1-GFP reporter was measured by outlining the fat body observed in the DAPI channel and measuring the mean gray value from the unadjusted images in the GFP channel and subtracting the mean background using ImageJ 1.45s (https://imagej.nih.gov/ij/). For immunofluorescence, ovaries were washed with PBS-T (PBS+0.3% Triton X-100 [Sigma, T8787]), permeabilized with 0.5% Triton X-100 and blocked with 2% BSA (Sigma, A2153) in PBS-T after fixation. The cleaved Dcp-1 antibody (Cell Signaling Technology, 9578) was diluted in 0.5% BSA+ PBS-T and incubated overnight at 4°C. Secondary antibodies anti-rabbit Alexa Fluor 546 or Alexa Fluor 488 (Invitrogen, A-11010, A-11008) were incubated at room temperature for 2 h and subsequently washed with PBS-T. Slides were then mounted as described above. All microscopy images were acquired at room temperature using one of 3 confocal apparatuses. Confocal images were taken using a Nikon Confocal C1 microscope equipped with a Plan APO 60X/1.45 oil immersion objective (Nikon, Melville, NY USA) with EZ-C1 Ver 3.00 software (Nikon), Nikon A1R Eclipse Ti inverted Laser Scanning Confocal Microscope with a Plan APO 60X/1.40 oil immersion objective (Nikon, Melville, NY USA) with acquisition software NIS Elements AR 4.2 (Nikon), and Leica TCS SP8 inverted confocal microscope with a Leica HC PL APO 63x/1.40 oil objective and LAS AF software (Leica, Buffalo Grove, IL USA). The pinhole and laser brightness settings were kept constant by applying the same properties between comparable experiments. Brightness and contrast were adjusted using Photoshop (CC 2014, Adobe) and applied to the whole image.

LysoTracker® Red and TUNEL stains in ovaries and larval fat bodies

Ovaries were dissected in PBS 3 or 4 d after eclosion. Larval fat bodies were dissected in PBS from first in-star larva. Both tissues were then incubated with 50 μM LTR DND-99 (Invitrogen, L-7528) in PBS for 3 min in the dark. Tissues were washed 3 times with PBS and then fixed for 20 min with 4% paraformaldehyde in PBS. For TUNEL staining, fixed tissues were washed 3 times with PBS + 0.1% Triton-X-100. TUNEL reaction was performed using the DeadEnd Fluorimetric Tunel System (Promega, G3250). Samples were mounted as described above.

Protein extraction and western blot analysis

Cell, ovary and whole body lysates were extracted using RIPA lysis buffer (Santa Cruz Biotechnology, sc-24948) plus complete protease inhibitors (Roche, 11697498002). Proteins were quantified using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, PI23228). Proteins were separated on a 4–12% or 10% NuPAGE Bis-Tris gels (Invitrogen, NP/0335 or NP0316) and transferred to PVDF membranes (Bio-Rad, 170-5061). Membranes were blocked in milk or Odyssey blocking buffer (LI-COR Inc., 927-40003) and incubated in primary antibodies overnight at 4°C. Primary antibodies included mouse anti-ACTA/actin (1:500, Developmental Studies Hybridoma Bank, JLA20), mouse anti-TUBB/tubulin (1:1000, Developmental Studies Hybridoma Bank, E7), rabbit anti-Dcp-1 (1:1000, a gift from K. McCall; Boston University, Boston, MA), and rabbit anti-HSP90 (1:1000, Cell Signaling Technology, 4874S). Membranes were incubated with HRP-conjugated secondary antibodies (Santa Cruz Biotech, SC2004/SC2005) or IR-labeled secondary antibodies (VWR, 610–132–121/610–132–122) and were detected using the Amersham ECL™ Enhanced Western Blotting System (VWR, RPN2106, Radnor, PA, USA) or the Odyssey System (LI-COR Biosciences, 927-40003, Lincoln, NE USA). Densitometry was performed using Image Quant 5.1 software (GE Healthcare) or Image Lab 5.1 software (BioRad).

Purification of Dcp-1 and in vitro cleavage assays

For transfection experiments, 5 μg of His-V5-Dcp-1 or His-V5-Dcp-1 plasmid DNA was added to 1 mL of Grace's insect medium (Invitrogen, 11595–030) and vortexed to mix. 100 μl of Cellfectin II (Invitrogen, 10362–100) was added to the DNA-Grace mixture and was incubated for at least 30 min. Cells (3.75 × 106) in 4 mL of Grace medium were incubated with DNA-Grace-Cellfectin II transfection medium overnight. Schneider medium + 10% FBS (10 mL) was added back to the cells and the cells were incubated for an additional 3 d before Ni-NTA purification. Purification of His-V5-Dcp-1FL or His-V5-Dcp-1C
Ni-NTA Spin Columns (Thermo Fisher Scientific, 88224). Cells were resuspended in 400 μL of Equilibration Buffer (PBS, 10 mM imidazole, pH 7.4) with 1% Triton X-100 (Sigma, T8787), incubated on a rotary shaker at 4°C for 10 min and centrifuged at 22000 g at 4°C for 15 min to remove insoluble material. Supernatants were added to the Ni-NTA beads and mixed at 4°C for 30 min. The column was centrifuged at 22000 g at 4°C for 2 min to remove the flow-through. The columns were then washed 3 times with 400 μL of wash buffer (PBS, 25 mM imidazole), and His-tagged Dcp-1 was eluted 3 times with 200 μL of elution buffer (PBS, 250 mM imidazole). The elutions were assayed for caspase activity using the Caspase-Glo 3/7 Kit (Promega, G8091). Eluate (10 μL) was added to 100 μL of Caspase-Glo 3/7 Reagent and incubated at 25°C for 30 min. Luminescence was detected using the Wallac1420 Victor plate reader (Perkin Elmer, Waltham, MA USA). The elutions were immediately used for in vitro cleavage assays. The caspase reaction buffer used for in vitro cleavage assays was as described previously in. A 100-μL reaction consisting of increasing volumes of Ni-NTA purified Dcp-1FL or Dcp-1CHsp83 or Drice incubated in caspase reaction buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 2 mM DTT, 0.1% Triton X-100). The reaction mixture was incubated at 25°C overnight and precipitated with 400 μL of acetone for western blot analysis.

Quantitative RT-PCR (QRT-PCR) analysis

Flies were collected and ground in 1 mL TRIZOL (Ambion, 15596–026) and total RNA was extracted according to the manufacturer's instructions. RNA was treated with DNase, and QRT-PCR was performed using the One-Step SYBR green RT-PCR reagent kit (Applied Biosystems, 4389986) on a 7900 Sequence Detection System (Applied Biosystems, Foster City, CA USA). Expression levels were calculated using the comparative threshold method with Drosophila rp49 as a reference gene. QRT-PCR primers are as follows: rp49, 5’-ATACAGGCCCAAGATCGTGA-3’ and 5’-GCACTCTGTTGTCGATACCCTT-3’, and Dcp-1, 5’-CCGGAGTCTCTTGTGTTGGT-3’ and 5’-GTATTCGCTTGCATATCGTTCC-3’.

Proteasome activity assay

Animals were collected 3 to 4 d after eclosion and frozen immediately on dry ice. Microcentrifuge tubes were weighed before and after on an analytical balance to determine the mass. Whole bodies were ground and incubated for 30 min on ice in 0.5 mL of lysis buffer (50 mM HEPES, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Triton X-100). Lysates were then separated by centrifugation at 22000 g for 15 min at 4°C. In a 96-well black plate 50 μL of lysate was added to 50 μL of chymotrypsin-like, caspase-like, trypsin-like peptide substrates from the Proteasome-Glo kit (Promega, G8531). The substrates incubated with the lysates for 10 min before the luminescence reading was measured on a Synergy H4 Hybrid (BioTek, Winooski, VT USA). Relative luminescence was then determined proportionally to total mass per sample.

MG132 treatment

Flies were fed a final concentration of 50 μM of MG132 (Cedarlane, A2585g-10mg) resuspended in DMSO and diluted with 5% sucrose (Sigma, 84097) and green food coloring. This solution was aliquoted onto wet yeast paste and fed to flies for 4 d. The control solution had the same concentrations of DMSO, sucrose and food coloring without MG132. Ingestion of the solutions was indicated by green food coloring visible in the abdomen.

Statistics

In each graph, data represent standard error of mean (SEM) of n independent experiments. As indicated in the legends, statistical significance was calculated by analysis of variance (ANOVA) plus a Dunnett or Bonferroni post test, or a 2-tailed Student t test between the indicated samples using GraphPad Prism (GraphPad Software). P values are shown in the legends.
  46 in total

1.  Role and regulation of starvation-induced autophagy in the Drosophila fat body.

Authors:  Ryan C Scott; Oren Schuldiner; Thomas P Neufeld
Journal:  Dev Cell       Date:  2004-08       Impact factor: 12.270

2.  HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.

Authors:  Atsushi Iwata; Brigit E Riley; Jennifer A Johnston; Ron R Kopito
Journal:  J Biol Chem       Date:  2005-09-28       Impact factor: 5.157

3.  The initiator caspase Dronc is subject of enhanced autophagy upon proteasome impairment in Drosophila.

Authors:  T V Lee; H E Kamber Kaya; R Simin; E H Baehrecke; A Bergmann
Journal:  Cell Death Differ       Date:  2016-04-22       Impact factor: 15.828

Review 4.  The biology of proteostasis in aging and disease.

Authors:  Johnathan Labbadia; Richard I Morimoto
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

5.  Cell death in ovarian chambers of Drosophila melanogaster.

Authors:  F Giorgi; P Deri
Journal:  J Embryol Exp Morphol       Date:  1976-06

6.  High HSP90 expression is associated with decreased survival in breast cancer.

Authors:  Elah Pick; Yuval Kluger; Jennifer M Giltnane; Christopher Moeder; Robert L Camp; David L Rimm; Harriet M Kluger
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

Review 7.  Targeting the dynamic HSP90 complex in cancer.

Authors:  Jane Trepel; Mehdi Mollapour; Giuseppe Giaccone; Len Neckers
Journal:  Nat Rev Cancer       Date:  2010-08       Impact factor: 60.716

Review 8.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Authors:  D Chen; M Frezza; S Schmitt; J Kanwar; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

9.  Germline cell death is inhibited by P-element insertions disrupting the dcp-1/pita nested gene pair in Drosophila.

Authors:  Bonni Laundrie; Jeanne S Peterson; Jason S Baum; Jeffrey C Chang; Dana Fileppo; Sharona R Thompson; Kimberly McCall
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

10.  IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms.

Authors:  Tencho Tenev; Anna Zachariou; Rebecca Wilson; Mark Ditzel; Pascal Meier
Journal:  Nat Cell Biol       Date:  2004-12-05       Impact factor: 28.824

View more
  5 in total

1.  Elevation of major constitutive heat shock proteins is heat shock factor independent and essential for establishment and growth of Lgl loss and Yorkie gain-mediated tumors in Drosophila.

Authors:  Gunjan Singh; Saptomee Chakraborty; Subhash C Lakhotia
Journal:  Cell Stress Chaperones       Date:  2022-06-15       Impact factor: 3.827

2.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

3.  Hypoxia-induced 26S proteasome dysfunction increases immunogenicity of mesenchymal stem cells.

Authors:  Ejlal Abu-El-Rub; Glen Lester Sequiera; Niketa Sareen; Weiang Yan; Meenal Moudgil; Mohammad Golam Sabbir; Sanjiv Dhingra
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

Review 4.  The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors.

Authors:  Zhen Dong; Hongjuan Cui
Journal:  Cells       Date:  2018-12-20       Impact factor: 6.600

5.  The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

Authors:  Kaushik Bhattacharya; Lorenz Weidenauer; Tania Morán Luengo; Ellis C Pieters; Pablo C Echeverría; Lilia Bernasconi; Diana Wider; Yashar Sadian; Margreet B Koopman; Matthieu Villemin; Christoph Bauer; Stefan G D Rüdiger; Manfredo Quadroni; Didier Picard
Journal:  Nat Commun       Date:  2020-11-25       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.